APWA
ABBV icon

Atlas Private Wealth Advisors’s AbbVie ABBV Stock Holding History

Atlas Private Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$425K Sell
1,688
-187
-10% -$40.2K 0.09% 95
2026
Q1 		$408K Sell
1,875
-83
-4% -$18.4K 0.1% 93
2025
Q4 		$447K Buy
1,958
+2
+0.1% +$456 0.1% 86
2025
Q3 		$453K Sell
1,956
-2,185
-53% -$445K 0.11% 89
2025
Q2 		$769K Sell
4,141
-520
-11% -$96.6K 0.1% 100
2025
Q1 		$976K Buy
4,661
+154
+3% +$29.9K 0.14% 79
2024
Q4 		$801K Sell
4,507
-193
-4% -$35.5K 0.11% 81
2024
Q3 		$928K Buy
4,700
+7
+0.1% +$1.31K 0.13% 70
2024
Q2 		$805K Buy
4,693
+2,350
+100% +$389K 0.13% 72
2024
Q1 		$427K Sell
2,343
-2,085
-47% -$359K 0.14% 69
2023
Q4 		$686K Sell
4,428
-662
-13% -$96.5K 0.13% 68
2023
Q3 		$759K Buy
5,090
+2,241
+79% +$329K 0.14% 87
2023
Q2 		$384K Buy
2,849
+1,206
+73% +$177K 0.08% 126
2023
Q1 		$262K Buy
1,643
+193
+13% +$29.5K 0.12% 108
2022
Q4 		$234K Buy
+1,450
New +$222K 0.12% 115
2022
Q3 		– Sell
-1,305
Closed -$200K – 126
2022
Q2 		$200K Buy
1,305
+1
+0.1% +$153 0.12% 125
2022
Q1 		$211K Buy
+1,304
New +$189K 0.09% 127
2021
Q4 		– Sell
-1,320
Closed -$142K – 144
2021
Q3 		$142K Buy
1,320
+20
+2% +$2.29K 0.07% 151
2021
Q2 		$146K Buy
1,300
+183
+16% +$20.6K 0.08% 136
2021
Q1 		$121K Buy
1,117
+154
+16% +$16.5K 0.07% 145
2020
Q4 		$103K Hold
963
– – 0.07% 154
2020
Q3 		$84K Buy
963
+200
+26% +$18.8K 0.07% 152
2020
Q2 		$75K Buy
+763
New +$67.2K 0.07% 165

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Atlas Private Wealth Advisors's ABBV Position: Q2 2026 in Review

Atlas Private Wealth Advisors reduced its AbbVie (ABBV) stake by 10% in Q2 2026, selling an estimated $40.2K and leaving 1,688 shares worth $425K. The position accounts for 0.09% of the portfolio, ranked #95.

Atlas Private Wealth Advisors first reported a position in ABBV in Q2 2020 and has held it in 23 quarters since. The position peaked at $976K in Q1 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Atlas Private Wealth Advisors held 1,688 shares of AbbVie worth $425K as of Q2 2026.
  • Atlas Private Wealth Advisors sold 187 AbbVie shares in Q2 2026, an estimated $40.2K.
  • AbbVie made up 0.09% of Atlas Private Wealth Advisors's portfolio in Q2 2026, its #95 holding.
  • Atlas Private Wealth Advisors first reported a position in AbbVie in Q2 2020 and has held it in 23 quarters since.
  • Atlas Private Wealth Advisors's AbbVie position peaked at $976K in Q1 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Atlas Private Wealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.